Consolidated Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Revenues	$ 16,146
Costs and operating expenses
Cost of revenues	475
Research and development	58,747	$ 49,586
General and administrative	25,420	32,610
Impairment of in-process research and development intangible asset	20,964	0
Total costs and operating expenses	105,606	82,196
Loss from operations	(89,460)	(82,196)
Other income, net
Interest and investment income	7,039	6,630
Sublease income	2,926	1,776
Total other income, net	9,965	8,406
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest, Total	(79,495)	(73,790)
Income tax benefit	(2,164)
Net loss	$ (77,331)	$ (73,790)
Net loss per common share - basic	$ (1.32)	$ (1.85)
Net loss per common share - diluted	$ (1.32)	$ (1.85)
Weighted average shares of common stock outstanding - basic	58,445,765	39,904,603
Weighted average shares of common stock outstanding - diluted	58,445,765	39,904,603
Other comprehensive income
Net unrealized gains on marketable debt securities	$ 107	$ 63
Other comprehensive income	107	63
Comprehensive loss	(77,224)	$ (73,727)
Royalty Revenues
Revenues	8,146
Sale of Royalty Rights
Revenues	$ 8,000